Page last updated: 2024-10-21

2,3-piperidinedicarboxylic acid and Chronic Primary Open Angle Glaucoma

2,3-piperidinedicarboxylic acid has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies

2,3-piperidinedicarboxylic acid: effective antagonist at all three types of excitatory amino acid receptors; does not depress responses to acetylcholine or substance P

Research Excerpts

ExcerptRelevanceReference
"To determine whether anterior ischemic optic neuropathy and compressive optic neuropathy in humans alter the photopic flash ERG and to investigate the cellular origins of the waves that are affected by pharmacologic agents in primates."1.32Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina. ( Bahrani, HM; Dorotheo, EU; Frishman, LJ; Rangaswamy, NV; Schiffman, JS; Tang, RA, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rangaswamy, NV1
Frishman, LJ1
Dorotheo, EU1
Schiffman, JS1
Bahrani, HM1
Tang, RA1

Other Studies

1 other study available for 2,3-piperidinedicarboxylic acid and Chronic Primary Open Angle Glaucoma

ArticleYear
Photopic ERGs in patients with optic neuropathies: comparison with primate ERGs after pharmacologic blockade of inner retina.
    Investigative ophthalmology & visual science, 2004, Volume: 45, Issue:10

    Topics: Adult; Aged; Animals; Electroretinography; Female; Glaucoma, Open-Angle; Humans; Light; Macaca mulat

2004